(Q44431121)

English

Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Matthes-Martin S

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lion T

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Aberle SW

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Fritsch G

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lawitschka A

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bittner B

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Frommlet F

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Gadner H

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Peters C

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

803-808

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Cytolytic activity against allogeneic human endothelia: resistance of cytomegalovirus-infected cells and virally activated lysis of uninfected cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

21 January 2018

Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

CMV antigenemia following bone marrow transplantation: risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection in recipients of related and unrelated donor bone marrow transplants: no evidence of increased incidence in patients receiving unrelated donor grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703927

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703927

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44431121&oldid=2206640720"